Search - tctmd.com

Displaying 141 - 160 of 215

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Update on Mitral Valve Disease and Transcatheter Therapies for Non-Aortic Valves

Presentation Fellows 2018

Cerebral Embolic Protection: A New Standard of Care?

Presenter: Susheel K. Kodali

April 15, 2018

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Presenter: Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Steven R. Bailey, Patrick W. Serruys, Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube

November 01, 2017

Presentation TCT 2017

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Presenter: Charles J. Davidson, Mathew Williams, Julia Seeger

November 01, 2017

Presentation TCT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3

Presenter: Francesco Saia, Gerhard C. Schuler, Pieter R. Stella

October 31, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Advertisement

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Cerebral Embolic Protection: A New Standard of Care?

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

When to Use Cerebral Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Cerebral Protection During TAVR: Routine vs Selective Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content